Your browser doesn't support javascript.
loading
Outcome of patients with metastatic sarcomatoid renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Kyriakopoulos, Christos E; Chittoria, Namita; Choueiri, Toni K; Kroeger, Nils; Lee, Jae-Lyun; Srinivas, Sandy; Knox, Jennifer J; Bjarnason, Georg A; Ernst, Scott D; Wood, Lori A; Vaishampayan, Ulka N; Agarwal, Neeraj; Pal, Sumanta K; Kanesvaran, Ravindran; Rha, Sun-Young; Yuasa, Takeshi; Donskov, Frede; North, Scott A; Heng, Daniel Y; Rini, Brian I.
Afiliação
  • Kyriakopoulos CE; Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH. Electronic address: ckyriakopou@gmail.com.
  • Chittoria N; Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.
  • Choueiri TK; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Kroeger N; Department of Urology, University Hospital of Greifswald, Greifswald, Germany.
  • Lee JL; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Srinivas S; Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.
  • Knox JJ; Department of Medicine, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Bjarnason GA; Department of Medical Oncology, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
  • Ernst SD; Department of Medical Oncology, Western University, London, Ontario, Canada.
  • Wood LA; Department of Medicine and Urology, Queen Elizabeth II Health Sciences Center, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Vaishampayan UN; Department of Medical Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI.
  • Agarwal N; Department of Medical Oncology, University of Utah Huntsman Cancer Institute, Salt Lake City, UT.
  • Pal SK; Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA.
  • Kanesvaran R; Department of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Rha SY; Department of Internal Medicine, Yonsei Cancer Center, Yonsei University Health System, Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea.
  • Yuasa T; Departments of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Donskov F; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
  • North SA; Department of Oncology, Cross Cancer Center, University of Alberta, Edmonton, Alberta, Canada.
  • Heng DY; Department of Medical Oncology, Tom Baker Cancer Center, University of Calgary, Calgary, Alberta, Canada.
  • Rini BI; Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.
Clin Genitourin Cancer ; 13(2): e79-85, 2015 Apr.
Article em En | MEDLINE | ID: mdl-25450036
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Inibidores da Angiogênese / Neoplasias Renais / Recidiva Local de Neoplasia / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Inibidores da Angiogênese / Neoplasias Renais / Recidiva Local de Neoplasia / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article